These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1700008)

  • 1. Mast cells as sources of cytokines, chemokines, and growth factors.
    Mukai K; Tsai M; Saito H; Galli SJ
    Immunol Rev; 2018 Mar; 282(1):121-150. PubMed ID: 29431212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic effects of ingested Lactobacillus rhamnosus: inhibition of mast cell membrane potassium (IKCa) current and degranulation.
    Forsythe P; Wang B; Khambati I; Kunze WA
    PLoS One; 2012; 7(7):e41234. PubMed ID: 22815978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatments for food allergy: how close are we?
    Wang J; Sampson HA
    Immunol Res; 2012 Dec; 54(1-3):83-94. PubMed ID: 22434517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food allergy: recent advances in pathophysiology and treatment.
    Wang J; Sampson HA
    Allergy Asthma Immunol Res; 2009 Oct; 1(1):19-29. PubMed ID: 20224666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A protease activated receptor-2 (PAR-2) activating peptide, tc-LIGRLO-NH2, induces protease release from mast cells: role in TNF degradation.
    Alshurafa HN; Stenton GR; Wallace JL; Hollenberg MD; Befus AD; Vliagoftis H
    BMC Pharmacol; 2004 Jul; 4():12. PubMed ID: 15265236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential signaling and induction of allergy-promoting lymphokines upon weak stimulation of the high affinity IgE receptor on mast cells.
    Gonzalez-Espinosa C; Odom S; Olivera A; Hobson JP; Martinez ME; Oliveira-Dos-Santos A; Barra L; Spiegel S; Penninger JM; Rivera J
    J Exp Med; 2003 Jun; 197(11):1453-65. PubMed ID: 12782712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human alpha-2a interferon promotes an atypical process of mast cell secretion with ultrastructural features suggestive for piecemeal degranulation.
    Crivellato E; Candussio L; Mallardi F; Ribatti D
    J Anat; 2002 Dec; 201(6):507-12. PubMed ID: 12489762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redundancy or cell-type-specific regulation? Tumour necrosis factor in alveolar macrophages and mast cells.
    Déry RE; Lin TJ; Befus AD; Milne CD; Moqbel R; Ménard G; Bissonnette EY
    Immunology; 2000 Mar; 99(3):427-34. PubMed ID: 10712673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide.
    Wills FL; Gilchrist M; Befus AD
    Immunology; 1999 Jul; 97(3):481-9. PubMed ID: 10447771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal effects of interleukin-4 and interferon-gamma on immunoglobulin E-mediated mast cell degranulation: a role for nitric oxide but not peroxynitrite or cyclic guanosine monophosphate.
    Deschoolmeester ML; Eastmond NC; Dearman RJ; Kimber I; Basketter DA; Coleman JW
    Immunology; 1999 Jan; 96(1):138-44. PubMed ID: 10233688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The strain difference in the effect of mercuric chloride on antigen-triggered serotonin release from rat mast cells is not mediated via interferon-gamma.
    Hodson D; Oliveira DB
    Immunology; 1996 Nov; 89(3):463-7. PubMed ID: 8958063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell factor potentiates histamine secretion by multiple mechanisms, but does not affect tumour necrosis factor-alpha release from rat mast cells.
    Lin TJ; Bissonnette EY; Hirsh A; Befus AD
    Immunology; 1996 Oct; 89(2):301-7. PubMed ID: 8943730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of IFN-gamma with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells.
    Holliday MR; Banks EM; Dearman RJ; Kimber I; Coleman JW
    Immunology; 1994 May; 82(1):70-4. PubMed ID: 8045595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of tumour necrosis factor-alpha (TNF-alpha) release from mast cells by the anti-inflammatory drugs, sodium cromoglycate and nedocromil sodium.
    Bissonnette EY; Enciso JA; Befus AD
    Clin Exp Immunol; 1995 Oct; 102(1):78-84. PubMed ID: 7554404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-activating factor synthesis by peritoneal mast cells and its inhibition by two quinoline-based compounds.
    Hogaboam CM; Donigi-Gale D; Shoupe TS; Bissonnette EY; Befus AD; Wallace JL
    Br J Pharmacol; 1992 Jan; 105(1):87-92. PubMed ID: 1596692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of mast cell-mediated cytotoxicity by IFN-alpha/beta and -gamma.
    Bissonnette EY; Befus AD
    J Immunol; 1990 Nov; 145(10):3385-90. PubMed ID: 1700008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferons differentially regulate histamine and TNF-alpha in rat intestinal mucosal mast cells.
    Bissonnette EY; Chin B; Befus AD
    Immunology; 1995 Sep; 86(1):12-7. PubMed ID: 7590871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGF-beta1 inhibits the release of histamine and tumor necrosis factor-alpha from mast cells through an autocrine pathway.
    Bissonnette EY; Enciso JA; Befus AD
    Am J Respir Cell Mol Biol; 1997 Mar; 16(3):275-82. PubMed ID: 9070612
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.